Merck Wins European Approval for First-Ever Ebola Vaccine Merck Wins European Approval for First-Ever Ebola Vaccine

U.S. drugmaker Merck& Co Inc on Monday received approval from the European Commission to market its Ebola vaccine, less than a month after a European medicines panel backed the first-ever vaccine against the deadly virus.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news